Izadi Vasafi Gh, Firoozabadi M M
PhD, Department of Physics, Faculty of Sciences, University of Birjand, Birjand, Iran.
J Biomed Phys Eng. 2019 Dec 1;9(6):653-660. doi: 10.31661/jbpe.v0i0.799. eCollection 2019 Dec.
The amount of average dose enhancement in tumor loaded with B may vary due to various factors in boron neutron capture therapy.
This study aims to evaluate dose enhancement in tumor loaded with B under influence of various factors and investigate the dependence of this dose enhancement on neutron spectra changes.
In this simulation study, using Cf as a neutron source, the average in-tumor dose enhancement factor (DEF) and neutron energy spectra were calculated for various B concentrations, phantom with different sizes and for different tumor locations, through MCNPX code.
Obtained results showed that the values of average DEF rise with increasing B concentration, phantom diameter (˂ 30 cm) and tumor distance from the source, but this increment is not linear.
It was concluded that inequality in average dose enhancement rates, in tumor loaded with B under influence of various factors in boron neutron capture therapy, is due to non-identical changes of both the thermal neutron flux with increasing same number of B atoms and same thickness of scattering material, and the thermal to fast neutron flux ratio with increasing equal distances of tumor from the source.
在硼中子俘获治疗中,含硼肿瘤内的平均剂量增强量可能因多种因素而有所不同。
本研究旨在评估多种因素影响下含硼肿瘤的剂量增强情况,并研究这种剂量增强对中子能谱变化的依赖性。
在本模拟研究中,以Cf作为中子源,通过MCNPX程序,针对不同的硼浓度、不同尺寸的模体以及不同的肿瘤位置,计算肿瘤内平均剂量增强因子(DEF)和中子能谱。
所得结果表明,平均DEF值随硼浓度、模体直径(˂ 30 cm)以及肿瘤与源的距离增加而升高,但这种增加并非呈线性关系。
得出的结论是,在硼中子俘获治疗中多种因素影响下,含硼肿瘤内平均剂量增强率存在差异,这是由于随着相同数量的硼原子和相同厚度的散射材料增加,热中子通量的变化不同,以及随着肿瘤与源的距离等距增加,热中子与快中子通量比的变化不同所致。